Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Anthony @ Equity Investigations, Dear Anthony, -- Ignore unavailable to you. Want to Upgrade?

To: QuietWon who wrote (18987)	3/10/1999 10:15:00 AM
From: Doorman	Read Replies (2) \| Respond to of 122087

<The only thing that seems to explain it Was the co went from 12 to 84 and everyone remembers the name and trades it.< That's probably the biggest reason. Additional factors are that the media has kept ENMD on its radar screen (especially Boston Globe stories that have been picked up by national wire services and cable outlets like MSNBC) and the fact that they are the only biotech company besides IMGN that has shown complete eradication on tumors in mice. What is impressive about the climb back to 25 is that huge volume has not accompanied it...

To: QuietWon who wrote (18987)	3/10/1999 10:27:00 AM
From: Mike Ankley	Respond to of 122087

According to Yahoo, I believe there is some Biotech conference coming up (next week?), where numerous papers/announcements will be presented. I think that ENMD is rising in anticipation of this. LONGS not selling and some short covering. You can almost guarantee, something will be announced from some Biotech company causing them all to have a short term rise. I believe ENMD is a great short, but after the short pop caused by this anticipation. Cheers Mike